Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study

The aim of the study was to evaluate the safety and efficacy of a new chemo-radiotherapy regimen for patients with locally advanced pancreatic cancer (LAPC). Patients were treated as follows: gemcitabine 1000 mg/m(2) on day 1, and oxaliplatin 100 mg/m(2) on day 2, every two weeks (GEMOX regimen) for...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancers (Basel)
Egile Nagusiak: Passardi, Alessandro, Scarpi, Emanuela, Neri, Elisa, Parisi, Elisabetta, Ghigi, Giulia, Ercolani, Giorgio, Gardini, Andrea, La Barba, Giuliano, Pagan, Flavia, Casadei-Gardini, Andrea, Valgiusti, Martina, Ferroni, Fabio, Frassineti, Giovanni Luca, Romeo, Antonino
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6562444/
https://ncbi.nlm.nih.gov/pubmed/31086093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11050663
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak